Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
暂无分享,去创建一个
S. Matskeplishvili | V. Pavlov | L. Fiedler | I. Lakman | R. Pistulli | L. Motloch | B. Cai | M. Mirna | P. Jirak | N. Zagidullin | A. Tyurin | A. Topf | U. Hoppe | P. Davtyan | R. Gumerov | D. Gareeva | Kristen Kopp | Benzhi Cai